Hepatitis B virus vaccine. Cost-benefit analysis of its use in a children's hospital

Ralph Hicks, J. W. Cullen, M. A. Jackson, F. Burry

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A cost-benefit analysis of routine active immunization against hepatitis B virus (HBV) for 500 nursing personnel at The Children's Mercy Hospital in Kansas City, Missouri, is described. Based on outcomes of HBV infection, local charges for medical care and wages lost from illness, the authors calculate the average cost per case of HBV infection to be $1,990. Including the current system of postexposure prophylaxis and an annual attack rate of 1 percent the current annual cost of HBV infection in The Children's Mercy Hospital is $12,630. The HBV immunization program would have to continue for 15 years before it cumulative costs ($189,133) were exceeded by those of the current system ($189,450). Therefore routine immunization of nurses would not be cost effective in the near future. If, however, a subset of high-risk employees with a 2 percent attack rate is identified, or the cost of the HBV vaccine series fell from the current $103 to $27, then routine immunization would become cost beneficial within 6 years.

Original languageEnglish (US)
Pages (from-to)359-365
Number of pages7
JournalClinical Pediatrics
Volume28
Issue number8
StatePublished - 1989
Externally publishedYes

Fingerprint

Hepatitis B Vaccines
Hepatitis B virus
Cost-Benefit Analysis
Costs and Cost Analysis
Virus Diseases
Immunization
Nurses
Immunization Programs
Salaries and Fringe Benefits
Vaccination

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Hepatitis B virus vaccine. Cost-benefit analysis of its use in a children's hospital. / Hicks, Ralph; Cullen, J. W.; Jackson, M. A.; Burry, F.

In: Clinical Pediatrics, Vol. 28, No. 8, 1989, p. 359-365.

Research output: Contribution to journalArticle

Hicks, R, Cullen, JW, Jackson, MA & Burry, F 1989, 'Hepatitis B virus vaccine. Cost-benefit analysis of its use in a children's hospital', Clinical Pediatrics, vol. 28, no. 8, pp. 359-365.
Hicks, Ralph ; Cullen, J. W. ; Jackson, M. A. ; Burry, F. / Hepatitis B virus vaccine. Cost-benefit analysis of its use in a children's hospital. In: Clinical Pediatrics. 1989 ; Vol. 28, No. 8. pp. 359-365.
@article{05d3b15c3bdb4a06a6d5c341402bb8b2,
title = "Hepatitis B virus vaccine. Cost-benefit analysis of its use in a children's hospital",
abstract = "A cost-benefit analysis of routine active immunization against hepatitis B virus (HBV) for 500 nursing personnel at The Children's Mercy Hospital in Kansas City, Missouri, is described. Based on outcomes of HBV infection, local charges for medical care and wages lost from illness, the authors calculate the average cost per case of HBV infection to be $1,990. Including the current system of postexposure prophylaxis and an annual attack rate of 1 percent the current annual cost of HBV infection in The Children's Mercy Hospital is $12,630. The HBV immunization program would have to continue for 15 years before it cumulative costs ($189,133) were exceeded by those of the current system ($189,450). Therefore routine immunization of nurses would not be cost effective in the near future. If, however, a subset of high-risk employees with a 2 percent attack rate is identified, or the cost of the HBV vaccine series fell from the current $103 to $27, then routine immunization would become cost beneficial within 6 years.",
author = "Ralph Hicks and Cullen, {J. W.} and Jackson, {M. A.} and F. Burry",
year = "1989",
language = "English (US)",
volume = "28",
pages = "359--365",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Inc.",
number = "8",

}

TY - JOUR

T1 - Hepatitis B virus vaccine. Cost-benefit analysis of its use in a children's hospital

AU - Hicks, Ralph

AU - Cullen, J. W.

AU - Jackson, M. A.

AU - Burry, F.

PY - 1989

Y1 - 1989

N2 - A cost-benefit analysis of routine active immunization against hepatitis B virus (HBV) for 500 nursing personnel at The Children's Mercy Hospital in Kansas City, Missouri, is described. Based on outcomes of HBV infection, local charges for medical care and wages lost from illness, the authors calculate the average cost per case of HBV infection to be $1,990. Including the current system of postexposure prophylaxis and an annual attack rate of 1 percent the current annual cost of HBV infection in The Children's Mercy Hospital is $12,630. The HBV immunization program would have to continue for 15 years before it cumulative costs ($189,133) were exceeded by those of the current system ($189,450). Therefore routine immunization of nurses would not be cost effective in the near future. If, however, a subset of high-risk employees with a 2 percent attack rate is identified, or the cost of the HBV vaccine series fell from the current $103 to $27, then routine immunization would become cost beneficial within 6 years.

AB - A cost-benefit analysis of routine active immunization against hepatitis B virus (HBV) for 500 nursing personnel at The Children's Mercy Hospital in Kansas City, Missouri, is described. Based on outcomes of HBV infection, local charges for medical care and wages lost from illness, the authors calculate the average cost per case of HBV infection to be $1,990. Including the current system of postexposure prophylaxis and an annual attack rate of 1 percent the current annual cost of HBV infection in The Children's Mercy Hospital is $12,630. The HBV immunization program would have to continue for 15 years before it cumulative costs ($189,133) were exceeded by those of the current system ($189,450). Therefore routine immunization of nurses would not be cost effective in the near future. If, however, a subset of high-risk employees with a 2 percent attack rate is identified, or the cost of the HBV vaccine series fell from the current $103 to $27, then routine immunization would become cost beneficial within 6 years.

UR - http://www.scopus.com/inward/record.url?scp=0024373752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024373752&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 359

EP - 365

JO - Clinical Pediatrics

JF - Clinical Pediatrics

SN - 0009-9228

IS - 8

ER -